药物洗脱支架与冠状动脉旁路移植术在无保护左主干病变合并慢性肾衰竭患者中的预后分析
该研究纳入353例无保护左主干病变合并慢性肾衰竭患者,按eGFR分层为<45组(150例)和45-59组(203例),比较DES与CABG的长期预后。平均随访30.74±15.05个月,Log-Rank分析显示各eGFR分层两组MACCE、全因死亡、心源性死亡和卒中发生率均无显著差异。但eGFR 45-59组DES的TVR比例高于CABG(18.8% vs. 0.8%,P<0.01),eGFR<45组DES的心梗发生率高于CABG(10.4% vs. 1.2%,P<0.05);Cox回归校正后上述差异仍显著。结论提示eGFR<45是DES的独立危险因素,严重CRF患者选择DES需谨慎。
要点
- eGFR<45 mL×min-1×1.73 m-2是ULM合并CRF患者行DES的独立危险因素,该组DES心梗发生率10.4% vs. CABG 1.2%(P<0.05)。
- eGFR 45-59 mL×min-1×1.73 m-2组DES的TVR比例18.8% vs. CABG 0.8%(P<0.01),Cox校正后HR=46.463(95%CI 4.558-473.693,P=0.001)。
- eGFR<45组DES心梗Cox校正后HR=14.098(95%CI 1.123-176.988,P=0.040),该组TVR两种方式无差异。
- 各eGFR分层DES与CABG的MACCE、全因死亡、心源性死亡和卒中发生率均无显著差异(Log-Rank分析)。
- DES组完全血运重建比例及CTO、多支病变比例均低于CABG组,选择策略需结合冠脉病变复杂程度。
适用人群与场景
- 纳入:北京安贞医院心内科ICU和心脏外科ICU收治的无保护左主干冠状动脉病变合并慢性肾衰竭患者,共353例。
- 按eGFR分层:eGFR<45 mL×min-1×1.73 m-2组150例(DES 67例,CABG 83例);eGFR 45-59 mL×min-1×1.73 m-2组203例(DES 80例,CABG 123例)。
- 场景:心内科ICU及心脏外科ICU,病情阶段为住院期间接受血运重建决策的患者。
诊断标准与关键阈值
- 以eGFR分层:<45 mL×min-1×1.73 m-2和45-59 mL×min-1×1.73 m-2两层。
- 主要终点为MACCE,次要终点包括全因死亡、心源性死亡、卒中、TVR和心肌梗死。
- 原文未提及具体诊断标准名称及启动/停止阈值。
处置流程与药物剂量
- 原文未提及具体药物剂量、给药途径、频次或疗程。
- 血运重建策略选择:eGFR<45 mL×min-1×1.73 m-2患者行DES需谨慎选择,因DES组心梗发生率高于CABG(10.4% vs. 1.2%)。
- eGFR 45-59 mL×min-1×1.73 m-2患者行DES需注意TVR风险高于CABG(18.8% vs. 0.8%)。
红旗征与不能漏的情况
- eGFR<45 mL×min-1×1.73 m-2患者选择DES后心肌梗死风险显著高于CABG(HR=14.098,95%CI 1.123-176.988,P=0.040),需警惕围术期及远期心梗。
- eGFR 45-59 mL×min-1×1.73 m-2患者DES后TVR风险显著高于CABG(HR=46.463,95%CI 4.558-473.693,P=0.001),需监测靶血管再狭窄。
研究设计与关键结果
- 研究类型:回顾性队列分析,单中心(北京安贞医院),纳入353例无保护左主干合并慢性肾衰竭患者。
- 干预与对照:DES组 vs. CABG组,按eGFR<45和45-59两层分析。
- 主要终点:各eGFR分层两组MACCE发生率无显著差异(Log-Rank分析)。
- 关键次要终点:eGFR 45-59组DES的TVR比例18.8% vs. CABG 0.8%(P<0.01);eGFR<45组DES心梗发生率10.4% vs. CABG 1.2%(P<0.05)。
- Cox校正后:eGFR 45-59组TVR的HR=46.463(95%CI 4.558-473.693,P=0.001);eGFR<45组心梗HR=14.098(95%CI 1.123-176.988,P=0.040)。
- 平均随访(30.74±15.05)个月。
证据类型、等级与局限
- 证据类型:单中心回顾性队列研究。
- 局限:单中心、回顾性设计、样本量353例、非随机分组,DES组完全血运重建比例及CTO、多支病变比例低于CABG组,存在选择偏倚可能。
对床旁实践的改变
- 对于无保护左主干合并慢性肾衰竭患者,eGFR<45 mL×min-1×1.73 m-2时选择DES需谨慎,因心梗风险高于CABG。
- eGFR 45-59 mL×min-1×1.73 m-2患者若选择DES,需加强随访监测TVR,因TVR风险显著高于CABG。
- DES与CABG在MACCE、死亡和卒中方面无显著差异,策略选择应结合冠脉病变复杂程度(如CTO、多支病变)及完全血运重建可行性。
- 适用人群:无保护左主干病变合并慢性肾衰竭、eGFR 45-59或<45 mL×min-1×1.73 m-2的患者;原文未提及不适用人群。
指南或共识出处
- 原文未提及
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To analyze the long-term prognosis of undergoing drug-eluting stent implantation (DES) or coronary artery bypass grafting (CABG) in patients with unprotected left main (ULM) coronary artery disease complicated with chronic renal failure (CRF).
METHODS: Patients with UML coronary artery disease complicated with CRF admitted to the department of cardiology intensive care unit (ICU) and cardiac surgery ICU of Beijing Anzhen Hospital Affiliated to Capital Medical University were enrolled. According to the estimated glomerular filtration rate (eGFR), the patients were divided into two layers, and the clinical characteristics of DES patients and CABG patients were analyzed. Log-Rank method and Cox regression were used to analyze the coronary artery disease and long-term clinical prognosis of patients with two surgical strategies.
RESULTS: A total of 353 patients were enrolled, including 150 patients with eGFR < 45 mL×min-1×1.73 m-2 (DES 67 cases, CABG 83 cases), eGFR 45-59 mL×min-1×1.73 m-2 in 203 cases (DES 80 cases, CABG 123 cases). In terms of demography and clinical history, compared with CABG group, DES group had lower proportion of complete revascularization and lower proportion of chronic totalocclusion (CTO) and multi vessel disease in each eGFR level. All patients were followed up for an average of (30.74±15.05) months. Log-Rank analysis showed that there was no significant difference in the incidence of major cardiovascular and cerebrovascular adverse events (MACCE), all-cause death, cardiogenic death and stroke between DES group and CABG group in each eGFR level. In eGFR 45-59 mL×min-1×1.73 m-2, the proportion of target vessel revascularization (TVR) in DES group was higher than that in CABG group (18.8% vs. 0.8%, P < 0.01); in eGFR < 45 mL×min-1×1.73 m-2, the incidence of myocardial infarction in DES group was higher than that in CABG group (10.4% vs. 1.2%, P < 0.05). Cox analysis showed that after adjusting for age, gender, history of hypertension, diabetes, left ventricular ejection fraction, smoking history, previous cerebrovascular disease, complete revascularization, multiple vessel disease and CTO, TVR proportion in DES group was still higher than that in CABG group in eGFR 45-59 mL×min-1×1.73 m-2 [hazard ratio (HR) = 46.463, 95% confidence interval (95%CI) was 4.558-473.693, P = 0.001]; in eGFR < 45 mL×min-1×1.73 m-2, the incidence of myocardial infarction in DES group was still higher than that in CABG group (HR = 14.098, 95%CI was 1.123-176.988, P = 0.040), there was no difference in TVR proportion between the two methods.
CONCLUSIONS: eGFR < 45 mL×min-1×1.73 m-2 is an independent risk factor for DES in ULM patients. DES is safe and effective for ULM patients with CRF, but for patients with more severe CRF (eGFR < 45 mL×min-1×1.73 m-2), there was more myocardial infarction in DES group than that in CABG group, which should be carefully selected.
参考来源
- Pan Y, Mu Y, Zhang Y, et al. [Prognostic analysis of drug-eluting stent implantation and coronary artery bypass grafting in patients with unprotected left main coronary artery disease complicated with chronic renal failure]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2020. PMID: 33198864. doi:10.3760/cma.j.cn121430-20200518-00391
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。